HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pamela U Freda Selected Research

Pamela U Freda Research Topics

Disease

27Acromegaly
04/2021 - 04/2002
10Neoplasms (Cancer)
10/2014 - 08/2003
9Insulin Resistance
03/2021 - 05/2003
8Pituitary Neoplasms (Pituitary Adenoma)
12/2015 - 01/2003
4Pituitary ACTH Hypersecretion
04/2016 - 12/2008
3Hypopituitarism (Sheehan's Syndrome)
04/2020 - 10/2003
2Obesity
04/2016 - 10/2010
2Inappropriate ADH Syndrome (SIADH)
01/2016 - 01/2008
2Cushing Syndrome
10/2014 - 12/2008
2Growth hormone excess
02/2010 - 07/2006
2Hyperprolactinemia
01/2004 - 02/2003
1Diabetes Insipidus
01/2016
1Lipodystrophy
08/2015
1Body Weight (Weight, Body)
11/2014
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2014
1Ectopic ACTH Syndrome
10/2014
1Neuroendocrine Tumors (Neuroendocrine Tumor)
12/2011
1Flushing
12/2009
1Diarrhea
12/2009
1Pain (Aches)
12/2009
1Carcinoid Tumor (Carcinoid)
12/2009
1Malnutrition (Nutritional Deficiencies)
08/2009
1Thyroid Diseases (Thyroid Disease)
08/2009
1Adenoma (Adenomas)
12/2008
1Hypoglycemia (Reactive Hypoglycemia)
01/2005
1Nausea
01/2005
1Fatigue
01/2005
1Dizziness (Lightheadedness)
01/2005
1Vomiting
01/2005
1Diabetes Mellitus
05/2003
1Sepsis (Septicemia)
03/2003
1Inflammation (Inflammations)
03/2003
1Weight Loss (Weight Reduction)
02/2003

Drug/Important Bio-Agent (IBA)

25Insulin-Like Growth Factor I (IGF-1)IBA
04/2021 - 04/2002
9Growth Hormone (Somatotropin)IBA
03/2021 - 08/2003
8Glucose (Dextrose)FDA LinkGeneric
04/2021 - 01/2003
8Insulin (Novolin)FDA Link
03/2021 - 04/2002
7pegvisomantFDA LinkGeneric
03/2021 - 04/2002
6Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2009 - 07/2002
5Hormones (Hormone)IBA
04/2011 - 08/2003
4LeptinIBA
11/2019 - 03/2003
4Adrenocorticotropic Hormone (ACTH)FDA Link
10/2014 - 01/2005
3Octreotide (Sandostatin)FDA LinkGeneric
12/2009 - 05/2003
3Biomarkers (Surrogate Marker)IBA
08/2009 - 10/2003
3CabergolineFDA LinkGeneric
01/2004 - 02/2003
3Dopamine Agonists (Dopamine Agonist)IBA
01/2004 - 08/2003
2Insulin-Like PeptidesIBA
03/2021 - 08/2003
2Agouti-Related ProteinIBA
11/2019 - 10/2014
2LipidsIBA
08/2015 - 05/2012
2GhrelinIBA
11/2014 - 05/2003
2C-Reactive ProteinIBA
11/2014 - 05/2012
2Peptides (Polypeptides)IBA
12/2009 - 01/2003
2Somatotropin Receptors (Growth Hormone Receptor)IBA
07/2006 - 10/2003
2ProlactinIBA
01/2004 - 10/2003
2Bromocriptine (Parlodel)FDA LinkGeneric
01/2004 - 08/2003
1Vasopressins (Vasopressin)IBA
01/2016
1EnzymesIBA
03/2015
1HDL LipoproteinsIBA
11/2014
1Triglycerides (Triacylglycerol)IBA
11/2014
1Lipoprotein(a)IBA
11/2014
1HomocysteineIBA
11/2014
1NeuropeptidesIBA
10/2014
1Pro-Opiomelanocortin (Proopiomelanocortin)IBA
10/2014
1AdipokinesIBA
05/2012
1CholesterolIBA
05/2012
1AdiponectinIBA
05/2012
1Temozolomide (Temodar)FDA LinkGeneric
12/2011
1Capecitabine (Xeloda)FDA Link
12/2011
1GlucocorticoidsIBA
10/2010
1Biogenic Amines (Biogenic Amine)IBA
12/2009
1NitrogenIBA
08/2009
1ElectrolytesIBA
01/2008
1DNA (Deoxyribonucleic Acid)IBA
01/2007
1Codon (Codons)IBA
01/2007
1lanreotide (Somatuline)FDA Link
08/2005
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2005
1nalmefene (Revex)FDA Link
01/2005
1Pharmaceutical PreparationsIBA
10/2003
1quinagolideIBA
08/2003
1Indicators and Reagents (Reagents)IBA
08/2003

Therapy/Procedure

17Therapeutics
03/2021 - 04/2002
2Drug Therapy (Chemotherapy)
12/2011 - 10/2003
2Radiotherapy
07/2006 - 08/2003
1Aftercare (After-Treatment)
04/2016
1Adrenalectomy
12/2011